Diagnostic yield of a one sample immunochemical test at different cut-off values in an organised screening programme for colorectal cancer

European Journal of Cancer

Volumn 49, Issue 12, 2013, Pages 2727-2733

  Hamza, S ^a   Dancourt, V ^a,b   Lejeune, C ^a   Bidan, J M ^c   Lepage, C ^a   Faivre, J ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b ADECA 21 58 16 18 Rue Nodot ^*  (France)

^c Laboratoire du CES de la CPAM de Dijon   (France)

Author keywords

Colorectal cancer; Immunochemical faecal occult blood tests; Screening

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SCREENING; CANCER STAGING; CARCINOMA IN SITU; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; HUMAN; IMMUNOCHEMISTRY; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; OCCULT BLOOD TEST; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

COLORECTAL CANCER; IMMUNOCHEMICAL FAECAL OCCULT BLOOD TESTS; SCREENING;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HEMATOLOGIC TESTS; HUMANS; IMMUNOCHEMISTRY; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84879993742     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.03.023     Document Type: Article

References (23)

1. J. Ferlay, D.M. Parkin, and E. Steliarova-Foucher Estimates of cancer incidence and mortality in Europe in 2008 Eur J Cancer 46 2010 765 781
2. O. Kronborg, C. Fenger, and J. Olsen Randomized study as screening for colorectal cancer with faecal-occult-blood test Lancet 348 1996 1467 1471
3. J.D. Hardcastle, J.O. Chamberlain, and M.H. Robinson Randomized controlled trial of fecal-occult-blood screening for colorectal cancer Lancet 348 1996 1472 1477
4. J. Faivre, V. Dancourt, and C. Lejeune Reduction in colorectal cancer mortality by fecal occult blood screening in a controlled study in France Gastroenterology 126 2004 1674 1680
5. L.G. van Rossum, A.F. van Rijn, and R.J. Laheij Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population Gastroenterology 135 2008 82 90
6. L. Hol, M.E. van Leerdam, and M. van Ballegooijen Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy Gut 59 2010 62 68
7. L. Guittet, V. Bouvier, and N. Mariotte Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population Gut 56 2007 210 214
8. J. Faivre, V. Dancourt, and B. Denis Comparison between a guaiac and three immunochemical faecal occult blood tests in screening for colorectal cancer Eur J Cancer 48 2012 2969 2976
9. N. Segnan, J. Patnick, and L. von Karsa European guidelines for quality assurance in colorectal cancer screening and diagnosis 2010 Publication Office of the European Union Luxembourg
10. L. Guittet, V. Bouvier, and E. Guillaume Colorectal cancer screening: why immunochemical, fecal occult blood test performs as well with either one or two samples Dig Liver Dis 44 2012 694 699
11. J. Faivre, V. Dancourt, and S. Manfredi Positivity rates and performances of immunochemical faecal occult blood tests at different cut-off levels within a colorectal cancer screening programme Dig Liver Dis 44 2012 700 704
12. S.L. Goede, A.H.C. van Roon, and J.C.I. Reijerink Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening Gut 62 2013 727 734
13. Journal Officiel de la République Française. Arrêté du 29 septembre 2006 relatif aux programmes de dépistage des cancers. Annexe au n 295.32003-48.
14. L.H. Sobin, and Ch. Wittekind TNM classification of malignant tumours 7th ed. 2009 Wiley New York
15. L. Hol, J.A. Wilschut, and M. van Ballegooijen Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels Br J Cancer 100 2009 1103 1110
16. G. Grazzini, C.B. Visioli, and M. Zorzi Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? Br J Cancer 100 2009 259 265
17. L.G. van Rossum, A.F. van Rijn, and R.J. Laheij Cut off value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme Br J Cancer 101 2009 1274 1281
18. M.J. Denters, M. Deutekom, and P.M. Bossuyt Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer Gastroenterology 142 2012 497 504
19. S. Crotta, N. Segnan, and S. Paganin High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test Clin Gastroenterol Hepatol 10 2012 633 638
20. T. Morikawa, J. Kato, and Y. Yamaji A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population Gastroenterology 129 2005 422 428
21. S.I. Stryker, B.G. Wolf, C.E. Culpe, S.D. Libbe, D.M. Ilstrup, and R.I. Mc Carthy Natural history of untreated colonic polyps Gastroenterology 93 1987 1009 1013
22. A.H. Van Roon, J.A. Wilschut, and L. Hol Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance Clin Gastroenterol Hepatol 9 2011 333 339
23. V. Dancourt, C. Lejeune, C. Lepage, M.C. Gailliard, B. Meny, and J. Faivre Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms Eur J Cancer 44 2008 2254 2258